Publications by authors named "Merrill D Benson"

Claim this Profile
D
Detection of Circulating Transthyretin Amyloid Aggregates in Plasma: A Novel Biomarker for Transthyretin Amyloidosis.
Rose Pedretti, Lanie Wang, Mazen Hanna, Merrill D Benson, Justin L Grodin

Circulation· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy.
Binh An Nguyen, Virender Singh, Shumaila Afrin, Anna Yakubovska, Lanie Wang, Merrill Douglas Benson

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update.
Thomas H Brannagan, Teresa Coelho, Annabel K Wang, Michael J Polydefkis, Peter J Dyck, Merrill D Benson

J Neurol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis.
Yukio Ando, David Adams, Merrill D Benson, John L Berk, Violaine Planté-Bordeneuve

Amyloid· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue biopsy for the diagnosis of amyloidosis: experience from some centres.
Merrill D Benson, John L Berk, Angela Dispenzieri, Thibaud Damy, Julian D Gillmore

Amyloid· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-translational modification of amyloid a protein in patients with AA amyloidosis.
Barbara Kluve-Beckerman, Justin T Smith, Carlie Ivancic, Merrill D Benson

Amyloid· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy.
Teresa Coelho, Yukio Ando, Merrill D Benson, John L Berk, Márcia Waddington-Cruz

Neurol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data.
Nicholas J Viney, Shuling Guo, Li-Jung Tai, Brenda F Baker, Mariam Aghajan, Merrill D Benson

ESC Heart Fail· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Commentary: Advances in transthyretin amyloid cardiomyopathy.
Merrill D Benson, Noel R Dasgupta

Trends Cardiovasc Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.
Merrill D Benson, Joel N Buxbaum, David S Eisenberg, Giampaolo Merlini, Maria J M Saraiva

Amyloid· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis.
Teresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, Michelle K White, Asia Sikora Kessler, Merrill D Benson

J Neurol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotersen therapy of transthyretin amyloid cardiomyopathy.
Noel R Dasgupta, Stacy M Rissing, Jessica Smith, Jeesun Jung, Merrill D Benson

Amyloid· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALECT2 and NASH.
Oscar W Cummings, Noel R Dasgupta, Merrill D Benson

Amyloid· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotersen treatment for ATTR amyloidosis.
Merrill D Benson

Amyloid· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of ATTR cardiomyopathy with a TTR specific antisense oligonucleotide, inotersen.
Noel R Dasgupta, Merrill D Benson

Amyloid· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease.
Victoria E Thomas, Justin Smith, Merrill D Benson, Noel R Dasgupta

Neurodegener Dis Manag· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A transgenic mouse model reproduces human hereditary systemic amyloidosis.
Michèle Chabert, Xavier Rousset, Magali Colombat, Michel Lacasa, Hermine Kakanakou, Merrill D Benson

Kidney Int· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
Mitsuharu Ueda, Masamitsu Okada, Mineyuki Mizuguchi, Barbara Kluve-Beckerman, Kyosuke Kanenawa, Merrill D Benson

J Biol Chem· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils.
Lorena Saelices, Binh A Nguyen, Kevin Chung, Yifei Wang, Alfredo Ortega, Merrill D Benson

J Biol Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotersen (transthyretin-specific antisense oligonucleotide) for treatment of transthyretin amyloidosis.
Merrill D Benson, Noel R Dasgupta, Brett P Monia

Neurodegener Dis Manag· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.
Merrill D Benson, Joel N Buxbaum, David S Eisenberg, Giampaolo Merlini, Maria J M Saraiva

Amyloid· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.
Marcia Waddington-Cruz, Elizabeth J Ackermann, Michael Polydefkis, Stephen B Heitner, Peter J Dyck, Merrill D Benson

Amyloid· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.
Lorena Saelices, Kevin Chung, Ji H Lee, Whitaker Cohn, Julian P Whitelegge, Merrill D Benson

Proc Natl Acad Sci U S A· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
Merrill D Benson, Márcia Waddington-Cruz, John L Berk, Michael Polydefkis, Peter J Dyck

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy.
Merrill D Benson, Noel R Dasgupta, Stacy M Rissing, Jessica Smith, Harvey Feigenbaum

Amyloid· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis